PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2039096
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2039096
U.S. & Asia Pacific Portable Medical Oxygen Concentrators Market is estimated to be valued at USD 1,304.7 Mn in 2026 and is expected to reach USD 1,689.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,304.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.30% | 2033 Value Projection: | USD 1,689.8 Mn |
Portable oxygen concentrators or POCs are medical devices that use physical means to separate oxygen from the atmosphere in order to produce concentrated, medical-grade gas. Providing oxygen in low-resource environments, such as isolated areas, military combat zones, rural Emergency Medical Services (EMS), and during disasters, becomes costly and time-consuming.
Increasing launches of portable oxygen concentrators is expected to drive the market growth during the forecast period. For instance, in July 2020, OMRON Healthcare, an electronic company, launched portable Oxygen Concentrator which provides continuous supply of Oxygen (5L per minute) with over 90% high concentration output.
Increasing prevalence of respiratory disorders are expected to bolster growth of the U.S. & Asia Pacific portable medical oxygen concentrators market. For instance, an article published in Elsevier B.V., a Netherlands-based academic publishing company, in November 2022, the number of people with COPD in China was estimated to be 88.3 million in 2020 and projected to increase to 103.3 million by 2039.
Increasing availability of portable oxygen concentrators in the U.S. and Asia Pacific are expected to drive growth of market over the forecast period. For instance, in July 2021, Belluscura plc, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announced that it had signed its first U.S. distribution agreement for its X-PLO2R portable oxygen concentrator (POC) portfolio. The distributor, located on the East Coast of the U.S., is an established nationwide seller of supplemental oxygen equipment.